BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6356465)

  • 1. Mechanism of action of dipyridamole.
    Harker LA; Kadatz RA
    Thromb Res Suppl; 1983; 4():39-46. PubMed ID: 6356465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis.
    Schrör K
    Semin Thromb Hemost; 1997; 23(4):349-56. PubMed ID: 9263351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of platelets in thrombosis and hemostasis.
    Packham MA
    Can J Physiol Pharmacol; 1994 Mar; 72(3):278-84. PubMed ID: 8069774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin.
    Moncada S; Korbut R
    Lancet; 1978 Jun; 1(8077):1286-9. PubMed ID: 78050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological analysis of the activity of the adenosine uptake inhibitor, dipyridamole, on the sinoatrial and atrioventricular nodes of the guinea-pig.
    Meester BJ; Shankley NP; Welsh NJ; Meijler FL; Black JW
    Br J Pharmacol; 1998 Jun; 124(4):729-41. PubMed ID: 9690865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dipyridamole, a cGMP phosphodiesterase inhibitor, causes pulmonary vasodilation in the ovine fetus.
    Ziegler JW; Ivy DD; Fox JJ; Kinsella JP; Clarke WR; Abman SH
    Am J Physiol; 1995 Aug; 269(2 Pt 2):H473-9. PubMed ID: 7653611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dipyridamole on prostaglandin generation by human platelets and vessel walls.
    Mehta J; Mehta P; Hay D
    Prostaglandins; 1982 Dec; 24(6):751-61. PubMed ID: 6820166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipyridamole: a critical evaluation.
    Rivey MP; Alexander MR; Taylor JW
    Drug Intell Clin Pharm; 1984 Nov; 18(11):869-80. PubMed ID: 6389068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.
    Diener HC; Cunha L; Forbes C; Sivenius J; Smets P; Lowenthal A
    J Neurol Sci; 1996 Nov; 143(1-2):1-13. PubMed ID: 8981292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interplay between inflammation and thrombosis in COVID-19: Mechanisms, therapeutic strategies, and challenges.
    Ma L; Willey J
    Thromb Update; 2022 Aug; 8():100117. PubMed ID: 38620713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of Desialylation on the Drug Binding Affinity of Human Alpha-1-Acid Glycoprotein Assessed by Microscale Thermophoresis.
    Šeba T; Kerep R; Weitner T; Šoić D; Keser T; Lauc G; Gabričević M
    Pharmaceutics; 2024 Feb; 16(2):. PubMed ID: 38399284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelets and Thrombotic Antiphospholipid Syndrome.
    Tohidi-Esfahani I; Mittal P; Isenberg D; Cohen H; Efthymiou M
    J Clin Med; 2024 Jan; 13(3):. PubMed ID: 38337435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complications of exercise and pharmacologic stress echocardiography.
    Lee C; Dow S; Shah K; Henkin S; Taub C
    Front Cardiovasc Med; 2023; 10():1228613. PubMed ID: 37600036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual Antiplatelet Therapy: A Concise Review for Clinicians.
    Virk HUH; Escobar J; Rodriguez M; Bates ER; Khalid U; Jneid H; Birnbaum Y; Levine GN; Smith SC; Krittanawong C
    Life (Basel); 2023 Jul; 13(7):. PubMed ID: 37511955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Employing Indirect Adenosine 2
    Pacheco-Vergara MJ; Benalcázar-Jalkh EB; Nayak VV; Bergamo ETP; Cronstein B; Zétola AL; Weiss FP; Grossi JRA; Deliberador TM; Coelho PG; Witek L
    J Funct Biomater; 2023 Jun; 14(6):. PubMed ID: 37367272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New High-Throughput Screen Discovers Novel Ligands of Full-Length Nuclear Receptor LRH-1.
    Malabanan MM; Chapagain P; Haratipour Z; Choi WJ; Orun AR; Blind RD
    ACS Chem Biol; 2023 May; 18(5):1101-1114. PubMed ID: 37074920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibiting the glycerophosphodiesterase EDI3 in ER-HER2+ breast cancer cells resistant to HER2-targeted therapy reduces viability and tumour growth.
    Keller M; Rohlf K; Glotzbach A; Leonhardt G; Lüke S; Derksen K; Demirci Ö; Göçener D; AlWahsh M; Lambert J; Lindskog C; Schmidt M; Brenner W; Baumann M; Zent E; Zischinsky ML; Hellwig B; Madjar K; Rahnenführer J; Overbeck N; Reinders J; Cadenas C; Hengstler JG; Edlund K; Marchan R
    J Exp Clin Cancer Res; 2023 Jan; 42(1):25. PubMed ID: 36670508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Navigating Antiplatelet Treatment Options for Stroke: Evidence-Based and Pragmatic Strategies.
    Moustafa B; Testai FD
    Curr Neurol Neurosci Rep; 2022 Nov; 22(11):789-802. PubMed ID: 36227497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bicyclic 6 + 6 systems: the chemistry of pyrimido[4,5-
    Monier M; Abdel-Latif D; El-Mekabaty A; Elattar KM
    RSC Adv; 2019 Sep; 9(53):30835-30867. PubMed ID: 35558733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contemporary antiplatelet therapy for secondary stroke prevention: a narrative review of current literature and guidelines.
    Shah J; Liu S; Yu W
    Stroke Vasc Neurol; 2022 Oct; 7(5):406-414. PubMed ID: 35393359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.